![<i>CYP2C19</i>
and
<i>CES1</i>
polymorphisms and efficacy of clopidogrel and aspirin dual antiplatelet therapy in patients with symptomatic intracranial atherosclerotic disease]()
<i>CYP2C19</i>
and
<i>CES1</i>
polymorphisms and efficacy of clopidogrel and aspirin dual antiplatelet therapy in patients with symptomatic intracranial atherosclerotic diseaseHoh, Brian L.; Gong, Yan; McDonough, Caitrin W.; Waters, Michael F.; Royster, Adrienne J.; Sheehan, Tiffany O.; Burkley, Ben; Langaee, Taimour Y.; Mocco, J; Zuckerman, Scott L.; Mummareddy, Nishit; Stephens, Marcus L.; Ingram, Christie; Shaffer, Christian M.; Denny, Joshua C.; Brilliant, Murray H.; Kitchner, Terrie E.; Linneman, James G.; Roden, Dan M.; Johnson, Julie A. · Journal of Neurosurgery · 2015